CBIZ Investment Advisory Services’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.52K Sell
78
-417
-84% -$39.7K ﹤0.01% 174
2025
Q4
$40.1K Sell
495
-2
-0.4% -$172 ﹤0.01% 166
2025
Q3
$43.5K Buy
497
+75
+18% +$6.7K ﹤0.01% 143
2025
Q2
$35.1K Buy
422
+3
+0.7% +$251 ﹤0.01% 169
2025
Q1
$35.1K Sell
419
-2
-0.5% -$186 ﹤0.01% 146
2024
Q4
$38.8K Buy
421
+117
+38% +$11.3K ﹤0.01% 129
2024
Q3
$28.2K Buy
304
+20
+7% +$1.73K ﹤0.01% 147
2024
Q2
$23.3K Sell
284
-38
-12% -$2.79K ﹤0.01% 143
2024
Q1
$21.4K Buy
+322
New +$19.9K ﹤0.01% 170

Other funds holding LMAT

CBIZ Investment Advisory Services's LMAT Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its LeMaitre Vascular (LMAT) stake by 84% in Q1 2026, selling an estimated $39.7K and leaving 78 shares worth $8.52K. The position accounts for ﹤0.01% of the portfolio, ranked #174.

CBIZ Investment Advisory Services first reported a position in LMAT in Q1 2024 and has held it in 9 quarters since. The position peaked at $43.5K in Q3 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • CBIZ Investment Advisory Services held 78 shares of LeMaitre Vascular worth $8.52K as of Q1 2026.
  • CBIZ Investment Advisory Services sold 417 LeMaitre Vascular shares in Q1 2026, an estimated $39.7K.
  • LeMaitre Vascular made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #174 holding.
  • CBIZ Investment Advisory Services first reported a position in LeMaitre Vascular in Q1 2024 and has held it in 9 quarters since.
  • CBIZ Investment Advisory Services's LeMaitre Vascular position peaked at $43.5K in Q3 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.